One of the Top US Cancer Centers Adopts MIM Software as Radiation Therapy Solution

CLEVELANDMarch 3, 2016 /PRNewswire/ -- MIM Software Inc., a leading global provider of medical imaging software, has recently collaborated with Memorial Sloan Kettering Cancer Center (MSK), nationally recognized by the National Cancer Institute and ranked by U.S. News & World Report as one of the top hospitals for cancer care in the country.

MSK will be using MIM Software's radiation oncology solution as a software source for handling dose accumulation, contour creation, image fusions and deformable registrations as well as a host of other clinical and research work. The software will be deployed at the main campus in Manhattan, along with all outpatient facilities that extend from Manhattan through the New York suburbs as well asNew Jersey and Long Island.

"In the ever increasing world of complex treatments for cancer, we are always looking to enhance our clinical workflow and advance the research we do," says Sandra Fontenla, Senior Physicist-Clinical Coordinator for External Beam at MSK.

"Radiation Therapy has become increasingly reliant on imaging for the safe and accurate treatment of cancer," Fontenla continues. "Our goal is to accomplish faster and more precise image registrations to enable physicians to identify tumors more quickly and accurately."

"Our mission at MIM Software has always been to enhance patient care and make an impact on cancer treatment," says Andrew Nelson, Chief Executive Officer of MIM Software. "We are privileged to work with one of the best cancer centers in the country and we look forward to a long-term relationship with MSK as they continue to make strides in cancer treatment and research."

About MIM Software Inc. 
MIM Software Inc. provides practical imaging solutions in the fields of radiation oncology, radiology, nuclear medicine, neuroimaging and cardiac imaging. MIM offers solutions for PC and Mac® workstations, mobile iOS and cloud-based platforms. MIM is a privately held company that sells its products globally to imaging centers, hospitals, specialty clinics, research organizations and pharmaceutical companies.

For more information, please visit www.mimsoftware.com.

SOURCE MIM Software Inc.

Around the web

CCTA is being utilized more and more for the diagnosis and management of suspected coronary artery disease. An international group of specialists shared their perspective on this ongoing trend.

The new technology shows early potential to make a significant impact on imaging workflows and patient care. 

Richard Heller III, MD, RSNA board member and senior VP of policy at Radiology Partners, offers an overview of policies in Congress that are directly impacting imaging.